Use of toll-like receptor and agonist for treating cancer

Details for Australian Patent Application No. 2010303464 (hide)

Owner Cleveland Biolabs, Inc.

Inventors Gudkov, Andrei V.

Agent Shelston IP

Pub. Number AU-A-2010303464

PCT Pub. Number WO2011/044246

Priority 61/249,596 07.10.09 US; 61/249,253 06.10.09 US

Filing date 6 October 2010

Wipo publication date 14 April 2011

International Classifications

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/044246 Priority application(s): WO2011/044246

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010303469-Preparation and use of stromal cells for treatment of cardiac diseases

2010303461-Integrated process to selectively convert renewable isobutanol to p-xylene